1. N. Howlader , M.Krapcho , J.Carshell , N.Neyman , S. F.Alterkruse , C. L.Kosary , M.Yu , J.Ruhl , Z.Zatalovich , H.Cho , A.Mariotto , D. R.Lewis , H. S.Chen , E. J.Feuer and K. A.Cronin , N.Howlader , A. M.Noone , M.Krapcho , J.Carshell , N.Neyman , S. F.Alterkruse , C. L.Kosary , M.Yu , J.Ruhl , Z.Zatalovich , H.Cho , A.Mariotto , R.Lewis , H. S.Chen and E. J.Feuer , SEER Cancer Statistics Review, 1975–2010, National Cancer Institute, Bethesda, MD , http://seer.cancer.gov/csr/1975-2010/ , based on November 2012 SEER data submission, posted to the SEER web site, April 2013
2. J. Ferlay , H. R.Shin , F.Bray , D.Forman , C.Mathers and D. M.Parkin , GLOBCAN , 2010, 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10, Lyon, France: International Agency for Research on Cancer, ( http://globocan.iarc.fr , 06/06/2016)
3. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs